SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Interim Management Statement

7 May 2014 12:19

RNS Number : 4739G
Carillion PLC
07 May 2014
 



7 MAY 2014

CARILLION PLC

AGM AND INTERIM MANAGEMENT STATEMENT

 

TRADING IN LINE WITH EXPECTATIONS

 

 

 

At Carillion plc's Annual General Meeting today, Chairman, Philip Rogerson, made the following comments on the Group's performance.

 

"Trading in the year to date is in line with our expectations and work winning has remained healthy.

 

"We continue to expect the Group to resume revenue growth in 2014, including the resumption of revenue growth in UK construction in the full year. As indicated when we announced our 2013 results, the Group's first-half revenue is likely to be slightly lower than in the first half of 2013, primarily because the planned rescaling of our UK construction activities continued throughout 2013, which resulted in the Group having a lower revenue run-rate at the year end.

 

"Being very selective in terms of the contracts for which we bid remains central to our strategy for supporting margins, which continue to be in line with our expectations. The investments we make in Public Private Partnership projects are also performing in line with our expectations. As previously indicated, the first-half and full-year contributions to Group profit from these investments will be lower than in 2013, because we plan to sell fewer investments in both periods in 2014.

 

"We continue to expect the Group to deliver cash-backed profit in 2014 and to return to positive net cash generation, with a consequent reduction in net borrowing at the year end. At the half year, net borrowing is expected to increase, compared with the position at 31 December 2013, primarily because payment of the final dividend in respect of 2013 will be made in June 2014. We continue to expect average net borrowing to fall in both the first half and full year.

 

"Work winning has continued to be healthy with £1.5 billion of new orders and probable orders in the year to date. Notable successes in support services include signing contracts for Royal Bank of Scotland, Arqiva and Canadian Natural Resources that together are worth £370 million. We have also been selected as the preferred bidder by the Nottingham University Hospitals NHS Trust for a support services contract worth approximately £200 million and as one of four framework contractors to deliver a £2 billion electrification programme for Network Rail. In the Middle East, we have signed contracts to build the Hard Rock Hotel in Abu Dhabi, Phase 1 of the Dubai World Trade Centre and Phase 2 of The Avenue Citywalk development in Dubai that together are worth £320 million. In addition, our pipeline of contract opportunities remains strong.

 

"In summary, although markets continue to be challenging, our expectations for 2014 remain unchanged. Furthermore, we believe the Group remains well positioned for the future as the medium-term outlook across our markets continues to improve."

 

For further information contact

Richard Adam, Group Finance Director tel: +44 (0) 1902 422431

John Denning, Group Corporate Affairs Director tel: +44 (0) 1902 316426

 

Finsbury

James Murgatroyd

Gordon Simpson tel: +44(0) 20 7251 3801

 

Notes to Editors

Carillion is a leading integrated support services company with a substantial portfolio of Public Private Partnership

projects and extensive construction capabilities. The Group had annual revenue in 2013 of some £4.1 billion, employs

around 40,000 people and operates across the UK, in the Middle East and Canada.

 

 The Group has four business segments:

 

 Support services - this includes facilities management, facilities services, energy services, utility services, road

 maintenance, rail services and consultancy services.

 

 Public Private Partnership (PPP) projects - this includes investing activities in PPP projects for Government buildings

 and infrastructure, mainly in the Defence, Health, Education, Transport and Secure accommodation sectors.

 

 Middle East construction services - this includes building and civil engineering activities in the Middle East.

 

 Construction services (excluding the Middle East) - this includes building, civil engineering and developments activities in

 the UK and construction activities in Canada.

 

 This and other Carillion news releases can be found at www.carillionplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUBAARSWAVRAR
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.